Interferon therapy for hepatitis C virus (HCV)-related advanced chronic hepatitis after treatment of recurrent hepatocellular carcinoma: A successful case

Internal Medicine

Volumn 41, Issue 3, 2002, Pages 202-206

  Kudo, Yoshikuni ^a,b,c   Terao, Hideo ^a,b,c   Arita, Tsuyoshi ^a,b,c   Kawasaki, Hisanori ^a,b,c   Sato, Shunzo ^a,b,c   Hisanori, A B E ^a,b,c   Fujioka, Masaaki Kodama Toshio ^a,b,c   Murakami, Kazunari ^a,b,c   Nasu, Masaru ^a,b,c  

^a Arita Icho Hospital   (Japan)

^b OITA UNIVERSITY   (Japan)

^c Kawasaki Medical Clinic   (Japan)

Author keywords

Complete response; Hepatic fibrosis; Prognosis; Quality of life (QOL); Readministration of interferon (IFN)

Indexed keywords

ALCOHOL; AMINOTRANSFERASE; BETA INTERFERON; HEPATITIS C ANTIBODY; RECOMBINANT ALPHA2B INTERFERON; VIRUS RNA; INTERFERON;

AGED; AMINOTRANSFERASE BLOOD LEVEL; ANTIBODY BLOOD LEVEL; ARTICLE; ARTIFICIAL EMBOLISM; CASE REPORT; CHRONIC HEPATITIS; COMPUTER ASSISTED TOMOGRAPHY; DRUG RESPONSE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HISTOLOGY; HUMAN; LAPAROSCOPY; LIVER BIOPSY; LIVER CELL CARCINOMA; MALE; PROTEINURIA; RECURRENT CANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; LIVER TUMOR; TUMOR RECURRENCE;

AGED; CARCINOMA, HEPATOCELLULAR; HEPATITIS C, CHRONIC; HUMANS; INTERFERONS; LIVER NEOPLASMS; MALE; NEOPLASM RECURRENCE, LOCAL;

EID: 0036203780     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.41.202     Document Type: Article

References (15)

1. Risk factors for tumor recurrence and prognosis after curative resection of hepatocellular carcinoma
2. Classification of chronic hepatitis: Diagnosis, grading and staging
3. Randomised trial of effects of interferon-α on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis
4. Alpha interferon treatment may prevent hepatocellular carcinoma in HCV-related liver cirrhosis
5. A successful case of interferon therapy for hepatitis C virus-related cirrhosis after treatment of hepatocellular carcinoma
6. Relationship between the recurrence of hepatocellular carcinoma (HCC) and serum alanine aminotransferase levels in hepatectomized patients with hepatitis C virus-associated cirrhosis and HCC
7. Interferon retreatment of nonresponders with HCV-RNA-positive chronic hepatitis C
8. Fluctuation patterns of HCV-RNA serum level in patients with chronic hepatitis C
9. Histologic improvement of fibrosis in patients with hepatitis C who have sustained response to interferon therapy
10. A case of type C cirrhosis with marked improvement of liver fibrosis after interferon therapy
11. Effect of interferon therapy on hepatocellular carcinogenesis in patients with chronic hepatitis type C: A long-term observation study of 1,643 patients using statistical bias correction with proportional hazard analysis
12. Fibrosis accelerates the development of enzyme-altered lesions in the rat liver
13. Interferon alpha inhibits intrahepatic recurrence in hepatocellular carcinoma with chronic hepatitis C: A pilot study
14. Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor - A prospective randomized study of hepatitis C virus-related liver cancer
15. Recombinant interferon-α in inoperable hepatocellular carcinoma: A randomized controlled trial